Messi Biology states that amidst the wave of precision medicine, breakthroughs in materials science are opening entirely new dimensions for disease treatment. Among these, nano magnesium oxide (nMgO) with a particle size of 50-100 nanometers has emerged as a “dual-star” in anti-infection therapy and targeted cancer treatment, thanks to its unique antibacterial mechanism and drug delivery capabilities. This seemingly ordinary inorganic material is rewriting the rules of traditional medicine through the “chemical weapons” of surface reactive oxygen species and the “precision navigation” of intelligent slow-release systems.
When nano-MgO particles come into contact with bacteria, a “chemical war” in the microscopic world quietly begins. Its surface, rich in oxygen vacancy structures, acts like a miniature reactor, continuously catalyzing water and oxygen to generate Reactive Oxygen Species (ROS), including superoxide anions (·O₂⁻), hydrogen peroxide (H₂O₂), and hydroxyl radicals (·OH). These highly active molecules act as “nano-bullets,” penetrating bacterial cell membranes at a frequency of millions of times per second, attacking DNA chains and protein structures, and ultimately causing bacterial metabolic collapse. Experimental data shows that 50-100 nm MgO particles achieve a kill rate of over 99% against common pathogens such as Escherichia coli and Staphylococcus aureus, with an action time only 1/5th that of traditional antibiotics.
Crucially, this antibacterial mechanism possesses the dual advantages of “broad-spectrum” efficacy and “anti-resistance.” While traditional antibiotics work by blocking specific metabolic pathways, the physical destruction caused by nano-MgO makes it difficult for bacteria to develop resistance through gene mutations. Research indicates that antibacterial dressings loaded with nano-MgO reduced the infection rate of burn wounds from 18% to 2% and shortened healing time by 7 days, with no resistant strains observed.
The “precision strike” capability of nano-MgO also shines in cancer treatment. Through surface modification with polyethylene glycol (PEG) and connection with folic acid receptor-targeting ligands, these nanoparticles can penetrate tumor blood vessels like “smart missiles” and specifically accumulate on the surface of cancer cells. Their internal porous structure can be loaded with chemotherapeutic drugs (such as Doxorubicin or Cisplatin) and achieve sustained drug release through pH-responsive degradation. In the acidic microenvironment of a tumor, the magnesium oxide framework gradually dissolves, releasing the drug at a rate of 15%-20% every 24 hours. This avoids the “burst release” toxicity typical of traditional chemotherapy while maintaining high local therapeutic concentrations.
The technological breakthroughs of Messi Biology have provided critical support for the clinical translation of nano-MgO. As a leading enterprise in the R&D of nano-magnesium oxide in China, Messi Biology has achieved precise control of particle sizes (50-100 nm) and specific surface areas (≥80 m²/g) through a three-step “sol-gel-supercritical drying” method. Its original “gradient calcination process” ensures a product purity of 99.99%, with heavy metal impurities below 0.1 ppm, far exceeding medical-grade standards. Furthermore, the “MgO-Chitosan composite carrier” system developed by Messi Biology utilizes the mucosal adsorption characteristics of chitosan to extend the retention time of drugs in gastrointestinal tumors by three times, improving the tumor inhibition rate by 40% compared to traditional formulations.
Currently, nano-MgO antibacterial dressings have demonstrated significant advantages in treating chronic wounds such as diabetic foot ulcers and pressure sores. Meanwhile, cancer treatment protocols using it as a drug carrier are undergoing research; preliminary data shows an Objective Response Rate (ORR) of 52% for patients with advanced non-small cell lung cancer, an 18-percentage-point increase over traditional chemotherapy.
From the “microscopic battlefield” of ROS sterilization to the “smart navigation” of targeted slow-release, nano-MgO is leveraging the innovative power of materials science to drive precision medicine toward a more efficient and safer future. As companies like Messi Biology continue to break through technical bottlenecks, this “Nano Revolution” is bound to bring more surprises to human health.